A series of clinical trials demonstrated that tumor treating fields is as efficient and effective as salvage chemotherapy, and has significantly fewer adverse effects than salvage chemotherapy.[19] Immunotherapy (e.g., PD-1/PD-L1) are also being conducted. The gene discussed is CD274; the disease is neoplasm.